| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
Papers In Press, published online ahead of print January 2, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
General Internal Medicine (463) and Rheumatology (470), Radboud University Nijmegen Medical Centre, Nijmegen 6525 GA
Corresponding Author: c.popa{at}aig.umcn.nl
The recent insight that inflammation contributes to the development of atherosclerosis and type 2 diabetes mellitus constitutes a major breakthrough in understanding the mechanisms underlying these conditions. In addition, it opens the way for new therapeutic approaches that might eventually decrease the prevalence of these public health problems. TNFa has been shown to play a key role in these processes and thus might be a potential therapeutic target. Increased concentrations of TNFa are found in acute and chronic inflammatory conditions (e.g. trauma, sepsis, infection, rheumatoid arthritis), in which a shift towards a pro-atherogenic lipid profile and impaired glucose tolerance occurs. While therapeutical blockade of TNFa worsens the prognosis in patients with abscesses and granulomatous infections, this strategy is highly beneficial in the case of chronic inflammatory conditions including rheumatoid arthritis. Current investigations assessing the impact of anti-TNF agents on intermediary metabolism suggest that TNFa blockade may improve insulin resistance and lipid profiles in patients with chronic inflammatory diseases.
Revised on January 2, 2007
Accepted on January 2, 2007
The role of TNF
in chronic inflammatory conditions, intermediary metabolism and cardiovascular risk
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Yu, J. Becnel, M. Zerfaoui, R. Rohatgi, A. H. Boulares, and C. D. Nichols Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor-{alpha}-Induced Inflammation with Extraordinary Potency J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 316 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Akirav, J. A. Kushner, and K. C. Herold {beta}-Cell Mass and Type 1 Diabetes: Going, Going, Gone? Diabetes, November 1, 2008; 57(11): 2883 - 2888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Lamon and D. P. Hajjar Inflammation at the Molecular Interface of Atherogenesis: An Anthropological Journey Am. J. Pathol., November 1, 2008; 173(5): 1253 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Montecucco and F. Mach Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis Rheumatology, October 16, 2008; (2008) ken395v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Egert, S. Wolffram, A. Bosy-Westphal, C. Boesch-Saadatmandi, A. E. Wagner, J. Frank, G. Rimbach, and M. J. Mueller Daily Quercetin Supplementation Dose-Dependently Increases Plasma Quercetin Concentrations in Healthy Humans J. Nutr., September 1, 2008; 138(9): 1615 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bartolome, B. Arteta, M. J. Martinez, Y. Chico, and B. Ochoa Kupffer cell products and interleukin 1? directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes Innate Immunity, August 1, 2008; 14(4): 255 - 266. [Abstract] [PDF]
|
|
|
|
 |
|
 H. G. Kim, J. Y. Kim, M. G. Gim, J. M. Lee, and D. K. Chung Mechanical stress induces tumor necrosis factor-{alpha} production through Ca2+ release-dependent TLR2 signaling Am J Physiol Cell Physiol, August 1, 2008; 295(2): C432 - C439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Oke and K. J. Tracey From CNI-1493 to the immunological homunculus: physiology of the inflammatory reflex J. Leukoc. Biol., March 1, 2008; 83(3): 512 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Di Comite and C. M. Rossi Risk of Diabetes in Patients With Rheumatoid Arthritis Taking Hydroxychloroquine JAMA, November 28, 2007; 298(20): 2368 - 2369. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Popa, F. H J van den Hoogen, T. R D J Radstake, M. G Netea, A. E Eijsbouts, M. d. Heijer, J. W M van der Meer, P. L C M van Riel, A. F H Stalenhoef, and P. Barrera Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis Ann Rheum Dis, November 1, 2007; 66(11): 1503 - 1507. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
